Literature DB >> 31801057

Fatty Liver Disease Caused by High-Alcohol-Producing Klebsiella pneumoniae.

Jing Yuan, Chen Chen, Jinghua Cui, Jing Lu, Chao Yan, Xiao Wei, Xiangna Zhao, NanNan Li, Shaoli Li, Guanhua Xue, Weiwei Cheng, Boxing Li, Huan Li, Weishi Lin, Changyu Tian, Jiangtao Zhao, Juqiang Han, Daizhi An, Qiong Zhang, Hong Wei, Minghua Zheng, Xuejun Ma, Wei Li, Xiao Chen, Zheng Zhang, Hui Zeng, Sun Ying, JianXin Wu, Ruifu Yang, Di Liu.   

Abstract

Entities:  

Year:  2019        PMID： 31801057     DOI： 10.1016/j.cmet.2019.11.006

Source DB:  PubMed          Journal:  Cell Metab        ISSN： 1550-4131            Impact factor:   27.287


× No keyword cloud information.
  25 in total

1.  An update on the role of the microbiome in non-alcoholic fatty liver disease pathogenesis, diagnosis, and treatment.

Authors:  Marialena Mouzaki; Rohit Loomba
Journal:  Curr Treat Options Gastroenterol       Date:  2020-05-02

Review 2.  Novel approaches to liver disease diagnosis and modeling.

Authors:  André G Oliveira; Romina Fiorotto
Journal:  Transl Gastroenterol Hepatol       Date:  2021-04-05

Review 3.  Hepatocellular Cancer and Gut Microbiome: Time to Untie Gordian's Knot.

Authors:  Cem Aygün; Nurdan Tözün
Journal:  J Gastrointest Cancer       Date:  2021-11-08

4.  Gut microbiome influences exercise response.

Authors:  Claire Greenhill
Journal:  Nat Rev Endocrinol       Date:  2020-02       Impact factor: 43.330

5.  Drivers of islet inflammation.

Authors:  Shimona Starling
Journal:  Nat Rev Endocrinol       Date:  2019-03       Impact factor: 43.330

Review 6.  Mechanistic and physiological approaches of fecal microbiota transplantation in the management of NAFLD.

Authors:  Manisha Gupta; Pawan Krishan; Amarjot Kaur; Sandeep Arora; Nirupma Trehanpati; Thakur Gurjeet Singh; Onkar Bedi
Journal:  Inflamm Res       Date:  2021-07-01       Impact factor: 4.575

Review 7.  Current Concepts, Opportunities, and Challenges of Gut Microbiome-Based Personalized Medicine in Nonalcoholic Fatty Liver Disease.

Authors:  S R Sharpton; B Schnabl; R Knight; R Loomba
Journal:  Cell Metab       Date:  2020-12-08       Impact factor: 31.373

Review 8.  Recent advances of sterile inflammation and inter-organ cross-talk in alcoholic liver disease.

Authors:  Young-Ri Shim; Won-Il Jeong
Journal:  Exp Mol Med       Date:  2020-05-26       Impact factor: 8.718

Review 9.  Human Gut Microbiome and Liver Diseases: From Correlation to Causation.

Authors:  Rui Li; Zhengsheng Mao; Xujun Ye; Tao Zuo
Journal:  Microorganisms       Date:  2021-05-08

Review 10.  A Role for Gut Microbiome Fermentative Pathways in Fatty Liver Disease Progression.

Authors:  Paula Iruzubieta; Juan M Medina; Raúl Fernández-López; Javier Crespo; Fernando de la Cruz
Journal:  J Clin Med       Date:  2020-05-07       Impact factor: 4.241
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.